Background and Purpose-The aim of this study was to determine if automated MRI analysis software (RAPID) can be used to identify patients with stroke in whom reperfusion is associated with an increased chance of good outcome. Methods-Baseline diffusion-and perfusion-weighted MRI scans from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution study (DEFUSE; nϭ74) and the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET; nϭ100) were reprocessed with RAPID. Based on RAPID-generated diffusion-weighted imaging and perfusion-weighted imaging lesion volumes, patients were categorized according to 3 prespecified MRI profiles that were hypothesized to predict benefit (Target Mismatch), harm (Malignant), and no effect (No Mismatch) from reperfusion. Favorable clinical response was defined as a National Institutes of Health Stroke Scale score of 0 to 1 or a Ն8-point improvement on the National Institutes of Health Stroke Scale score at Day 90. Results-In Target Mismatch patients, reperfusion was strongly associated with a favorable clinical response (OR, 5.6; 95% CI, 2.1 to 15.3) and attenuation of infarct growth (10Ϯ23 mL with reperfusion versus 40Ϯ44 mL without reperfusion; PϽ0.001). In Malignant profile patients, reperfusion was not associated with a favorable clinical response (OR, 0.74; 95% CI, 0.1 to 5.8) or attenuation of infarct growth (85Ϯ74 mL with reperfusion versus 95Ϯ79 mL without reperfusion; Pϭ0.7). Reperfusion was also not associated with a favorable clinical response (OR, 1.05; 95% CI, 0.1 to 9.4) or attenuation of lesion growth (10Ϯ15 mL with reperfusion versus 17Ϯ30 mL without reperfusion; Pϭ0.9) in No Mismatch patients. Conclusions-MRI profiles that are associated with a differential response to reperfusion can be identified with RAPID.
T reatment with intravenous tissue plasminogen activator (tPA), aimed at acutely restoring blood flow, reduces morbidity, but its use is limited by the need to start treatment within 4.5 hours of stroke onset. 1 It is, however, likely that the population of patients with stroke who present beyond 4.5 hours is heterogeneous and includes some patients who would still benefit from reperfusion. 2 Identification and effective treatment of the subgroup of patients who are likely to benefit would help reduce the burden of stroke. The combination of perfusion-(PWI) and diffusion-weighted MRI (DWI) is 1 of the most promising techniques to select patients who are likely to benefit from reperfusion. 3 The major drawback of this technique is that most currently available MRI processing algorithms require manual input and are therefore time-consuming and operator-dependent. To overcome these barriers, we designed RAPID, an operator-independent system for processing of PWI and DWI images. RAPID generates PWI and DWI maps, segments the PWI and DWI lesions, and calculates lesion volumes within 10 minutes of scan completion. These features make it an attractive tool for patient selection in acute stroke trials.
The overall aim of this study was to compare RAPID, an automated processing system, with processing methods that have been used in prior stroke studies. We determined if it can be used to identify, based on PWI and DWI lesion data, patients for whom reperfusion is associated with an increased chance of a good outcome. To achieve this goal, imaging data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution study (DEFUSE) and the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET), 4, 5 2 large prospective studies that have assessed the use of MRI for patient selection, were reprocessed using RAPID. A pooled data analysis was conducted on the reprocessed imaging data and the individual clinical data from both studies.
Methods

Studies
Data from 2 studies, DEFUSE and EPITHET, were included in this pooled analysis. 4, 5 Both studies were approved by local ethic committees and informed consent for participation was obtained from all patients in both studies. One patient who withdrew consent before treatment with the study drug and 1 patient whose follow-up clinical outcomes (modified Rankin Scale and National Institutes of Health Stroke Scale scores) were not obtained are not included in this pooled data set. DEFUSE was an open-label study of intravenous tPA administered in the 3-to 6-hour time window and EPITHET was a randomized placebo-controlled study of intravenous tPA in the 3-to 6-hour time window. Supplemental Table 1 (http://stroke.ahajournals. org) documents the similarities and differences between the 2 studies.
Pooling Methodology of Imaging Data
DWI and PWI data from DEFUSE and EPITHET were reprocessed in a standardized fashion using RAPID, an in-house-developed automated image processing software package. Lesion volumes assessed using RAPID were compared with lesion volumes determined by the local DEFUSE and EPITHET investigators as part of their original analyses. Regression coefficients describing the relationship between RAPID and original DEFUSE volumes and between RAPID and original EPITHET volumes were calculated for DWI and PWI data separately.
DWI Data
RAPID combines 2 independent methods to determine DWI lesion volumes: absolute and relative thresholding. The combination of these 2 methods was used to ensure that susceptibility pile-up artifacts, which appear hyperintense on b1000 images, were not falsely identified as acute stroke lesions. See Supplemental Textbox 1 for a description of RAPID's processing steps for DWI lesion segmentation. Regions of interest (ROIs), generated automatically by RAPID, were reviewed by a single investigator (D.A.D.), who manually excluded artifact from the ROI when indicated. DWI lesion volumes were calculated based on these corrected ROIs. This method differs from the method used in the original studies to assess DWI lesion volumes. In DEFUSE, DWI lesions were determined by a single reader using a semiautomated thresholding method in which voxels were included that exceeded the DWI signal intensity of a manually drawn control region in the contralateral hemisphere by Ͼ3 SDs. Artifacts were manually excluded from the lesion volume. In EPITHET, the DWI lesion was calculated by averaging the results of 2 readers who independently drew manual outlines of the DWI lesion on the b1000 map.
PWI Data
The original DEFUSE results were based on PWI maps generated by algorithms programmed in IDL and the original EPITHET results were based on PWI algorithms programmed in Matlab. RAPID is programmed in Cϩϩ. RAPID's process of calculating PWI lesion volumes is described in Supplemental Textbox 2 and has recently been published in detail. 6 The RAPID algorithm differs from the perfusion algorithms used in the original studies in 3 ways. First, RAPID has a built-in automated arterial input function (AIF) selection tool, whereas the DEFUSE algorithm relied on a manually selected AIF and the EPITHET algorithm on a semiautomated AIF selection tool.
Second, an AIF smoothing filter was used in the DEFUSE algorithm but not in the EPITHET and RAPID algorithms. 7 Third, the EPITHET algorithm deconvolved the tissue signal using standard singular value decomposition, whereas the DEFUSE and RAPID algorithms use circular deconvolution. 6 ROIs corresponding to the perfusion lesion on time to maximum (Tmax) maps, generated automatically by RAPID, were reviewed by a single investigator (D.A.D.), who manually excluded artifact from the ROIs when indicated. PWI lesion volumes at 4 Tmax thresholds (Ͼ4 seconds, Ͼ6 seconds, Ͼ8 seconds, and Ͼ10 seconds) were derived from the corrected ROIs. PWI Tmax Ͼ6 seconds lesion volumes were used for determination of mismatch status.
Final Infarct
Two investigators (S.C. and B.C.C.) independently reviewed all final infarct ROIs that were outlined by local investigators as part of the primary data analysis of the individual studies. Acute T2-weighted images were used to identify areas of pre-existing T2 hyperintensity. These areas were excluded from the final infarct. In cases in which either of the secondary reviewers (S.C. and B.C.C.) felt that the ROI outlined by the local investigator was inaccurate, a final lesion determination was reached through an adjudication panel (S.C., M.M., M.L.).
MR Angiography
For the pooled data analysis, 2 investigators (D.A.D. and M.L.) jointly reviewed all MR angiographic ratings that were obtained by local investigators as part of the primary data analysis of the individual studies and condensed these primary data by consensus into the following 2 variables: (1) site of obstruction (internal carotid artery, middle cerebral artery M1, middle cerebral artery M2, or posterior cerebral artery); and (2) degree of obstruction (complete, partial, none).
Hemorrhagic Transformation/Parenchymal Hematoma
For the pooled analysis, European Cooperative Acute Stroke Study (ECASS) categories of hemorrhagic transformation/parenchymal hematoma were used. 8 Presence of hemorrhage was adjudicated by a blinded committee in EPITHET and determined by a neuroradiologist in DEFUSE.
Definitions
MRI Profiles
Each patient with a sufficient quality PWI and DWI at baseline was categorized into 1 of 4 mutually exclusive predefined MRI profiles: Malignant is defined as a DWI or PWI Tmax Ͼ8 lesion Ͼ100 mL; Small is defined as a DWI lesion Ͻ10 mL and a PWI Tmax Ͼ6 lesion Ͻ10 mL. Small lesion patients by definition do not qualify as mismatch, which requires a Ͼ10-mL difference between DWI and PWI lesion volumes; Target Mismatch includes all patients whose imaging does not meet criteria for the Malignant or Small profiles and who have a ratio of PWI Tmax Ͼ6 lesion volume/DWI lesion volume Ͼ1.2 and an absolute difference between PWI Tmax Ͼ6 lesion volume and DWI lesion volume Ͼ10 mL; and No Mismatch includes all patients who do not meet criteria for Target Mismatch, Malignant, or Small lesion profiles.
Reperfusion
Reperfusion definitions and assessments that were used in the original analyses of the individual studies have been adopted for the pooled analysis; for patients who were enrolled in DEFUSE, a reduction in PWI Tmax Ͼ2 lesion volume of Ͼ30% and Ͼ10 mL between the baseline MRI and the 3-to 6-hour follow-up MRI qualifies as reperfusion; for EPITHET, a reduction in PWI Tmax Ն2 lesion volume of Ͼ90% and Ͼ10 mL between the baseline MRI and the 5-day follow-up MRI qualifies as reperfusion. More stringent reperfusion criteria were used for EPITHET subjects because reperfusion was assessed at a later time point (5 days) compared with DEFUSE (3 to 6 hours after tPA). Only patients with acceptable quality PWI data at baseline and at follow-up were included in reperfusion analyses. The effect of reperfusion was not assessed in patients with the "small lesion MR profile" because these patients, by definition, have a baseline PWI lesion volume that is too small (Ͻ10 mL) to qualify for reperfusion.
Recanalization is categorized as "none," "partial," or "complete" for patients with evidence of a symptomatic vessel obstruction on their baseline MR angiograph (MRA). Patients with any obstruction on baseline MRA and no improvement in MRA score on follow-up imaging are rated as "no recanalization." Patients with complete obstruction on baseline MRA and partial obstruction on follow-up MRA are rated as "partial recanalization." Patients with any obstruction on baseline MRA and no obstruction on follow-up MRA are rated as "complete recanalization."
Favorable clinical response is defined as an improvement of Ն8 points on the National Institutes of Health Stroke Scale score between baseline and 90 days or a score of 0 or 1 on the National Institutes of Health Stroke Scale score at 90 days.
Good functional outcome is defined as a score of Յ2 points on the modified Rankin Scale at 90 days.
Symptomatic Intracerebral Hemorrhage
The Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) symptomatic intracerebral hemorrhage criteria were adapted for the pooled analysis. 9 Lesion growth is defined as the difference between the T2/fluidattenuated inversion recovery lesion volume on the final follow-up MRI (Day 30 in DEFUSE; Day 90 in EPITHET) and the DWI lesion volume on the baseline scan.
Statistical Analysis
Standard descriptive statistics and comparisons between groups were performed using a commercially available statistical software package (SPSS Version 17.0). Tests used included the 2 and Fisher exact tests for dichotomous variables and the Mann-Whitney U and t tests for continuous data. Regression coefficients were also calculated using SPSS Version 17.0. Statistical tests were 2-tailed and statistical significance was defined at ␣Ͻ0.05. Unadjusted pooled ORs to describe the relationships between reperfusion on various clinical outcomes were calculated using a fixed effect model in SPSS Version 17.0 and in Review Manager 5 (RevMan computer program, Version 5.0, Copenhagen: The Nordic Cochrane Centre). Adjusted ORs were calculated using a logistic regression model in SPSS Version 17.0. Criterion to enter variables in the model was set at ␣Ͻ0.1. A backward stepwise method was used to eliminate variables from the model.
Results
Baseline characteristics of the DEFUSE and EPITHET study participants are listed in Table 1 . Compared with the DEFUSE patient cohort, patients enrolled in EPITHET were treated earlier, were more commonly hyperlipidemic, had larger DWI and PWI lesion volumes on their baseline MRI, and had larger mismatch volumes at their baseline evaluation.
DWI Data
RAPID was unable to process 2 cases. In both instances, failure resulted from incorrect b-value settings of the diffusion images. Lesion volumes obtained with RAPID correlated highly with DWI lesion volumes obtained for the original DEFUSE (R 2 ϭ0.87) and EPITHET (R 2 ϭ0.84) analyses but were consistently smaller than original DWI lesion volumes (Supplemental Figure) . There was a greater difference between original and RAPID-derived DWI lesion volumes in the EPITHET data set compared with the DEFUSE data set (39% mean difference in lesion volume in EPITHET versus 22% mean difference in DEFUSE; PϽ0.01).
PWI Data
RAPID was unable to generate an accurate baseline PWI lesion volume in 14 cases. Reasons for failure were severe head motion (nϭ5), no detectable gadolinium bolus (nϭ8), and scan not done (nϭ1). Five cases (1 DEFUSE case and 4 EPITHET cases) whose baseline PWI data were considered technically adequate to determine a lesion volume in the original analyses were deemed of insufficient quality for data analysis using RAPID. These data were excluded from the pooled analysis. Two DEFUSE cases whose PWI data were deemed insufficient for the original analysis were successfully processed using RAPID and were included in the pooled analysis. The correlation between original and RAPID-derived PWI lesion volumes was higher for DEFUSE cases than for EPITHET (R 2 ϭ0.84 for DEFUSE versus 0.56 for EPITHET; PϽ0.001; Supplemental Figure) . RAPID-derived PWI lesion volumes were smaller than the original PWI lesion volumes. The difference between original and RAPID-derived lesion volumes was greater for EPITHET cases (mean difference, 55%) than for DEFUSE cases (mean difference, 26%; PϽ0.01).
MRA and Recanalization
Baseline MRA data are summarized in Table 2 . There was a trend toward more patients with middle cerebral artery lesions in DEFUSE and more patients with internal carotid artery lesions or no MRA lesion in EPITHET ( 2 ϭ5.2; Pϭ0.08). Complete recanalization as assessed on the early follow-up scan (obtained at 3 to 6 hours after treatment in DEFUSE and 3 to 5 days after treatment in EPITHET) occurred in 16 of 47 (34%) DEFUSE cases and 15 of 48 (31%) EPITHET cases (Pϭ0.8; Table 2 ).
MRI Mismatch Profiles
Before standardization, there was no difference in the percentage of Target Mismatch patients between EPITHET and DEFUSE (54% versus 49%, Pϭ0.6), but the EPITHET study had more patients with the Malignant profile than DEFUSE (35% versus 9%, PϽ0.01) and fewer patients that had No Mismatch (6% versus 15%, Pϭ0.05). These differences in baseline MRI profiles between EPITHET and DEFUSE remained largely unchanged after standardized processing of PWI and DWI images with RAPID software. The Target Mismatch profile was present in 53% of the EPITHET study population and 51% of the DEFUSE population (Pϭ0.8); The Malignant profile was present in 25% and 9% (Pϭ0.01); and No Mismatch in 10% and 15% (Pϭ0.3), respectively. The interrater agreement in assessment of MR profile between original study criteria and RAPID was in the fair to good range (ϭ0.61; Supplemental Table 2 
Reperfusion
Reperfusion was strongly associated with a favorable clinical response in patients identified as having a Target Mismatch. The pooled OR for favorable clinical response associated with reperfusion in Target Mismatch patients was 5.6 (95% CI, 2.1 to 15.3; Pϭ0.001) when considering all patients and 5.6 (95% CI, 1.6 to 19.4; Pϭ0.006) when considering only tPA-treated patients (Figure 1 ). Using a multivariate logistic regression model to adjust for an imbalance in baseline National Institutes of Health Stroke Scale score, the OR for favorable outcome with reperfusion increased to 6.3 (95% CI, 2.2 to 18.0; Pϭ0.001). Reperfusion was also strongly associated with achieving a good functional outcome (defined as a modified Rankin Scale 0 to 2) at 90 days in Target Mismatch patients. Sixty-four percent (23 of 36) of Target Mismatch patients with reperfusion achieved a good functional outcome compared with 29% (11 of 38) of Target Mismatch patients without reperfusion (Pϭ0.003; Figure 2 ; Table 3 ). Percentages of poor functional outcome (modified Rankin Scale 5 to 6) were lower in Target Mismatch patients with reperfusion (3%) compared with Target Mismatch patients without reperfusion (29%; Pϭ0.002).
In contrast, there was no association between reperfusion and favorable clinical response in patients with the Malignant or No Mismatch patterns. The pooled OR for favorable clinical response after reperfusion was 0.74 (95% CI, 0.1 to 5.8; Pϭ0.8) for malignant patients and 1.05 (95% CI, 0.1 to 9.4; Pϭ1.0) for patients with No Mismatch when considering all patients (Figure 1 ). These results remained largely unchanged when limiting the analysis to the subgroup of patients who were treated with tPA. The OR for favorable clinical response after reperfusion was 0.5 (95% CI, 0.1 to 4.5; Pϭ0.5) for malignant patients and 1.4 (95% CI, 0.1 to Table 3 ).
Symptomatic intracerebral hemorrhage developed only in patients treated with tPA. Symptomatic intracerebral hemorrhage was not associated with reperfusion in Target Mismatch and No Mismatch patients but occurred more frequently in Malignant patients with reperfusion (50%) compared with Malignant patients without reperfusion (0%; Pϭ0.01).
Lesion growth, defined as the difference between final infarct volume and the baseline RAPID-derived DWI volume, was attenuated by reperfusion in Target Mismatch patients but not in Malignant and No Mismatch patients (Table 4) . These results were not altered by restricting the analysis to patients who were treated with tPA.
Discussion
This study has 2 important implications. First, the results indicate that assessment of DWI and PWI lesion volumes is highly dependent on the way the MRI images are processed and analyzed. This is illustrated by the fact that the methods used to determine DWI and PWI lesion volumes in the original DEFUSE study, the original EPITHET study, and this pooled analysis each yield different results. Thus, the use of DWI and PWI lesion criteria for patient selection in multicenter trials and, eventually, possibly also in clinical practice will require standardization of image processing methods across centers. Second, it demonstrates, in a large pooled cohort, that an automated MRI image analysis software suite (RAPID) can be used to identify patients for whom reperfusion is associated with an increased chance of good outcome. Consequently, RAPID processing of a baseline MRI study has the potential to determine if a patient is a good candidate to receive treatment aimed at restoring perfusion to the ischemic brain.
A standardized approach for DWI and PWI lesion volume assessment was applied. This was implemented by reprocessing and remeasuring the DWI and PWI lesion volumes using RAPID, an automated MRI analysis software suite. Previous studies that have pooled data from multiple sites have generally relied on volumetric assessments obtained locally. 10 Given the many different steps involved in lesion volume measurement, this approach almost inevitably leads to wide heterogeneity in terms of lesion volume assessment. Our data illustrate this. For the DEFUSE data, the original DWI volumes were approximately 20% larger than corresponding RAPID DWI volumes, whereas the original EPITHET DWI volumes were almost 40% larger than RAPID volumes. Differences between DEFUSE and EPITHET in DWI lesion assessment are likely the result of differences in the methods used to identify infarct core on DWI/apparent diffusion coefficient maps and in the selection of ROIs when manually outlining lesions. 
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A similar difference was seen for PWI assessments. The original DEFUSE PWI volumes were approximately 25% larger than corresponding RAPID PWI volumes, whereas the original EPITHET volumes were approximately 55% larger than the RAPID volumes. These differences are partially explained by the different Tmax thresholds used to identify tissue at risk in the 3 processing pipelines used to generate PWI maps. The Tmax threshold critically influences the volume of the PWI Tmax lesion; lower Tmax thresholds result in larger PWI lesions. Consequently, the shorter Tmax threshold used in EPITHET (Tmax Ն2) compared with DEFUSE (Tmax Ͼ2) in part explains why the original EPITHET PWI lesions were larger than original DEFUSE PWI lesions. Difference in the way the AIF was chosen (manual versus automatic) and the type of AIF filters used in the various PWI processing algorithms likely introduced additional variability.
As expected, the PWI volumes obtained by RAPID in this pooled analysis are smaller than original lesion volumes because RAPID uses a PWI Tmax threshold of Ͼ6 seconds. This relatively stringent threshold was chosen for 3 reasons. First, due to differences in the processing algorithm, RAPID yields somewhat larger volumes than the software programs used in DEFUSE and EPITHET for any given Tmax threshold. Second, the use of shorter Tmax thresholds in RAPID resulted in the inclusion of artifacts within the PWI lesion, which precludes the ability of RAPID to automatically segment PWI lesions. Third, the choice of a longer and thus more stringent Tmax threshold reduces the inclusion of benign oligemia in the PWI lesion, which results in better correlations between the baseline PWI lesion volume and the final infarct volume in patients who do not reperfuse. 11 This study demonstrates the feasibility of determining MRI profiles with automated image analysis software. RAPID's success rate for determining MRI profiles was 92%. The 8% failure rate was related to poor quality of the original PWI data either from severe patient motion (nϭ5) during image acquisition or because gadolinium contrast was not administered correctly (nϭ8). A newer beta-version of RAPID with improved motion correction capability is currently being tested and may further improve the success rate for determining MRI profiles in the acute stroke setting.
The results of RAPID-based patient selection in terms of patient outcome are encouraging and consistent with data from prior studies. The Target Mismatch was present in 52% mRS indicates modified Rankin Scale; SICH, symptomatic intracerebral hemorrhage defined according to Safe Implementation of Thrombolysis in Stroke-Monitoring Study criteria. Reperfusion was defined as a reduction in perfusion-weighted imaging (PWI) lesion volume between baseline and early follow-up of Ͼ30% and Ͼ10 mL for Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution subjects and Ͼ90% and Ͼ10 mL for Echoplanar Imaging Thrombolytic Evaluation Trial subjects. Mismatch profile was defined as a ratio between baseline PWI Tmax Ͼ6 s lesion and diffusion-weighted imaging (DWI) lesion Ͼ1.2 and an absolute difference between baseline PWI Tmax Ͼ6 s lesion and DWI lesion Ͼ10 mL. Malignant profile was defined as a baseline DWI lesion Ͼ100 mL or a PWI Tmax Ͼ8 s lesion Ͼ100 mL. Target Mismatch was defined as Mismatch patients who did not have the Malignant profile. Small lesion profile was defined as a baseline DWI lesion Ͻ10 mL and a baseline PWI Tmax Ͼ6 s lesion Ͻ10 mL; Tmax, time to maximum. *Favorable clinical response was defined as an improvement of Ն8 points in the National Institutes of Health Stroke Scale (NIHSS) score between baseline and 90 d or a score of 0 to 1 at 90 d.
†PՅ0.01 compared with patients with the same MR profile but without reperfusion. ‡PՅ0.001 compared with patients with the same MR profile but without reperfusion. Given the consistency with prior studies in terms of patient selection and outcome, it should be noted that RAPID-based patient selection does not identify patients who are better candidates for reperfusion therapy than conventional MRI processing methods. Instead, the main advantage of RAPID lies in its automated processing, which makes patient selection easier, faster, and more consistent.
The main limitation of this study is the inability to standardize the assessment of reperfusion between the EPITHET and DEFUSE cohorts. In EPITHET, reperfusion was assessed at 5 days based on Ͼ90% reduction in PWI volume, whereas in DEFUSE, reperfusion status was assessed 3 to 6 hours after administration of tPA based on Ͼ30% reduction in PWI volume. The percentage of reperfusion was similar in tPAtreated patient in EPITHET (56%) and DEFUSE (53%). Our estimates of the effect of reperfusion are probably conservative, because late assessment of reperfusion in EPITHET has likely diluted the effect of reperfusion in the pooled data set.
In summary, significant heterogeneity can be introduced by the use of differing image processing and lesion segmentation methods. Such heterogeneity can be eliminated by the use of RAPID, an automated MR image processing suite that provides an objective assessment of a patient's PWI and DWI lesion volumes. RAPID-generated quantitative DWI and PWI maps can be used to select patients in whom reperfusion is associated with an increased chance of good outcome. This makes automated image analysis software such as RAPID a potentially useful tool for patient selection in acute stroke trials.
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Study Design
Treatment allocation Open-label single arm study of IV tPA Double blind RCT of IV tPA
Treatment window 3 to 6 hours after symptom onset 3 to 6 hours after symptom onset Primary outcome measure Favorable clinical response defined as an improvement of 8 points or more on the NIHSS between baseline and 30 days or a score of 0-1 at day 30.
Infarct growth defined as the ratio of 90-day infarct volume over baseline DWI lesion volume
Primary analysis The odds ratio of favorable clinical response associated with reperfusion in mismatch patients
The difference in mean infarct growth between tPA and placebo in mismatch patients Inclusion criteria 1) 18 years or older 2) clinical diagnosis of ischemic stroke 3) NIHSS > 5 4) tPA start in 3 to 6 hour window 1) 18 years or older 2) acute hemispheric ischaemic stroke 3) NIHSS > 4 4) treatment in 3-6 hour time-window Exclusion criteria 1) comatose or severely obtunded 2) rapidly improving symptoms 3) a history of stroke within the last 6 weeks 4) premorbid mRS score of 3 or higher 5) seizure at symptom onset 6) previous intracranial hemorrhage 7) evidence of acute hemorrhage 8) clearly identifiable hypodensity involving more than one third of the MCA territory on the baseline non-contrast brain CT 1) premorbid mRS score of 3 or higher 2) acute hemorrhage on non-contrast CT 3) major early ischemic change (defined as ischaemia of more than one third of the MCA territory) 4) inability to undergo MRI 5) standard contraindications to alteplase 6) confounding neurological diseases such as dementia or life-threatening illness 
Processing steps for DWI lesion segmentation in RAPID
Step 1. DWI segmentation based on an absolute threshold: An absolute threshold of ADC < 615x10 -6 mm 2 /s was applied, followed by a morphologic opening operation with structural element size of 2 mm to remove spike noise in the mask obtained by thresholding.
Step 2 (M_b1000 + k * SD_b1000), and t_EA = (M_EA + k * SD_EA). The value of k was empirically determined to be 2.7. These thresholds were then applied to b1000 and EA maps to outline the lesion. Stroke core outlined using relative threshold was detected in voxels where both b1000 and EA values were above the respective thresholds simultaneously.
Step 3. The final DWI lesion was obtained as a union of the relative and absolute thresholding (i.e. at least one of the ADC-based or b1000/EA-based methods delivered positive identification).
Supplemental textbox 2.
Processing steps for PWI lesion segmentation in RAPID
Step 1. Patient motion in the raw PWI dynamic scans was corrected in-slice using 2D
spatial corregistration of individual timepoints to a mean image obtained by averaging of all timepoints.
Step 2. Measured MRI signals were converted to values of relative shortening of the transverse relaxivity.
Step 3. Arterial input function (AIF) was selected automatically by the software in location where signals with high amplitude, early arrival time, and belowaverage width were spatially clustered; the program ensured that only anatomically meaningful locations were considered. A typical result of the selection was AIF in the middle cerebral, internal carotid, or anterior cerebral arteries.
Step 4. After vascular signals were identified, a correction for nonlinear effect of gadolinium tracers in tissue and in bulk blood was applied.
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Step 5. Quantitative perfusion parameters (CBV, CBF, MTT, Tmax) were obtained by deconvolving tissue signals with the AIF. The deconvolution was applied in the frequency domain (equivalent to circular deconvolution), with a regularization filter that removed components with amplitude below 15% of the maximum component.
Step 6. The Tmax parameter was identified as the time of global maximum of the deconvolved tissue residue function.
Supplemental figure
Figure Legend for DEFUSE data compared with EPITHET data for both DWI (Fig A, p=0 .001 for difference between regression coefficients) and PWI (Fig B, p=0 .006 for difference between regression coefficients).
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Suppl Exclusion criteria 1) comatose or severely obtunded 2) rapidly improving symptoms 3) a history of stroke within the last 6 weeks 4) premorbid mRS score of 3 or higher 5) seizure at symptom onset 6) previous intracranial hemorrhage 7) evidence of acute hemorrhage 8) clearly identifiable hypodensity involving more than one third of the MCA territory on the baseline non-contrast brain CT 1) premorbid mRS score of 3 or higher 2) acute hemorrhage on non-contrast CT 3) major early ischemic change (defined as ischaemia of more than one third of the MCA territory) 4) inability to undergo MRI 5) standard contraindications to alteplase 6) confounding neurological diseases such as dementia or life-threatening illness The interrater agreement between the original study method and RAPID was good (kappa=0.61). Reclassification in terms of MR profile between original and RAPID-derived assessment occurred in 40 patients. It was generally the result of smaller RAPID derived PWI lesion volumes compared to original PWI lesion volumes.
Supplemental textbox 1.
Processing steps for DWI lesion segmentation in RAPID
Step 2. DWI segmentation based on relative thresholds: Mean (M) and standard deviation (SD) of the signal intensity in normal brain tissue was obtained for b=1000 (a.k.a. isotropic diffusion) and exponential-attenuation (EA) images; normal tissue was defined as tissue
with ADC values between 750 and 1900 x 10 -6 mm 2 /s. This yielded values of M_b1000, SD_b1000 and M_EA, SD_EA. Relative thresholds (t) were constructed: t_b1000 = (M_b1000 + k * SD_b1000), and t_EA = (M_EA + k * SD_EA). The value of k was empirically determined to be 2.7. These thresholds were then applied to b1000 and EA maps to outline the lesion. Stroke core outlined using relative threshold was detected in voxels where both b1000 and EA values were above the respective thresholds simultaneously.
Supplemental textbox 2.
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Supplemental figure
再灌流療法のための RAPID による自動的な患者選択
-Echoplanar Imaging Thrombolytic Evaluation Trial （ EPITHET ） および Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution （DEFUSE） 試験の統合解析
